Teva Pharmaceutical Industries Ltd (TEVA)
12.86
+0.08
(+0.63%)
USD |
NYSE |
Apr 19, 16:00
12.85
-0.01
(-0.08%)
After-Hours: 20:00
Teva Pharmaceutical Industries Revenue (TTM): 15.85B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.85B |
| September 30, 2023 | 15.27B |
| June 30, 2023 | 15.02B |
| March 31, 2023 | 14.92B |
| December 31, 2022 | 14.92B |
| September 30, 2022 | 15.14B |
| June 30, 2022 | 15.43B |
| March 31, 2022 | 15.56B |
| December 31, 2021 | 15.88B |
| September 30, 2021 | 16.23B |
| June 30, 2021 | 16.32B |
| March 31, 2021 | 16.28B |
| December 31, 2020 | 16.66B |
| September 30, 2020 | 16.67B |
| June 30, 2020 | 16.79B |
| March 31, 2020 | 17.09B |
| December 31, 2019 | 16.88B |
| September 30, 2019 | 16.39B |
| June 30, 2019 | 16.83B |
| March 31, 2019 | 17.35B |
| December 31, 2018 | 18.27B |
| September 30, 2018 | 19.16B |
| June 30, 2018 | 20.25B |
| March 31, 2018 | 21.27B |
| December 31, 2017 | 21.85B |
| Date | Value |
|---|---|
| September 30, 2017 | 23.48B |
| June 30, 2017 | 23.42B |
| March 31, 2017 | 22.74B |
| December 31, 2016 | 21.90B |
| September 30, 2016 | 20.29B |
| June 30, 2016 | 19.55B |
| March 31, 2016 | 19.48B |
| December 31, 2015 | 19.65B |
| September 30, 2015 | 19.94B |
| June 30, 2015 | 20.17B |
| March 31, 2015 | 20.25B |
| December 31, 2014 | 20.27B |
| September 30, 2014 | 20.53B |
| June 30, 2014 | 20.54B |
| March 31, 2014 | 20.41B |
| December 31, 2013 | 20.31B |
| September 30, 2013 | 20.13B |
| June 30, 2013 | 20.05B |
| March 31, 2013 | 20.12B |
| December 31, 2012 | 20.32B |
| September 30, 2012 | 20.74B |
| June 30, 2012 | 20.12B |
| March 31, 2012 | 19.33B |
| December 31, 2011 | 18.31B |
| September 30, 2011 | 17.05B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.92B
Minimum
Dec 2022
17.09B
Maximum
Mar 2020
16.01B
Average
16.23B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Viatris Inc | 15.43B |
| Alvotech | 91.43M |
| Johnson & Johnson | 89.66B |
| AbbVie Inc | 54.32B |
| Novartis AG | 51.01B |